CASP3 (Caspase 3)

Key executioner caspase in apoptosis and cellular homeostasis

Gene Information Card

Symbol CASP3
Full Name caspase 3
Gene Type protein-coding
Chromosomal Location 4q35.1
NCBI Gene ID 836 ncbi.nlm.nih.gov/gene/836
Ensembl ID ENSG00000164305
UniProt ID P42574
OMIM ID 600636
HGNC ID 1504
Aliases CPP32, CPP32B, SCA-1, Yama, apopain

Description

CASP3 (caspase 3) encodes a cysteine-aspartic acid protease that acts as a key executioner caspase in the apoptotic pathway. It is activated by initiator caspases (e.g., CASP8, CASP9) and cleaves multiple cellular substrates, including PARP1, leading to DNA fragmentation and cell death. CASP3 also participates in non-apoptotic processes such as cell differentiation, proliferation, and neural development.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (various) Reduced CASP3 expression or activity impairs apoptosis, promoting tumor survival and resistance to therapy. PMID: 12676586; COSMIC
Neurodegenerative disorders (e.g., Alzheimer disease) Aberrant CASP3 activation contributes to neuronal loss and tau cleavage. PMID: 15378065; OMIM #600636
Autoimmune lymphoproliferative syndrome (ALPS) Germline CASP3 mutations impair lymphocyte apoptosis, leading to lymphoproliferation. PMID: 20094044; ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.5 Medium
Spleen 15.2 Medium
Brain (cortex) 8.3 Low
Heart 6.1 Low
Thymus 18.7 Medium
Cell Line Expression
Cell Line nTPM Notes
HeLa 14.5 Cervical cancer cell line
HEK293 11.2 Embryonic kidney cells
Jurkat 20.1 T-cell leukemia line
MCF7 7.8 Breast cancer (low due to CASP3 deletion)
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.430C>T (p.Gln144*) Nonsense <0.1% Loss of function; truncation of caspase domain
c.497A>G (p.Asp166Gly) Missense <0.1% Impaired catalytic activity
c.1A>G (p.Met1?) Start loss <0.1% Loss of translation initiation
Mutation functional classification

Loss of Function (LOF)

Reduced or absent caspase 3 activity impairs apoptosis, contributing to cancer progression and immune dysregulation.

Gain of Function (GOF)

Not well documented; gain-of-function mutations are rare and may enhance apoptosis in neurodegenerative contexts.

Dominant Negative (DN)

Some missense mutations (e.g., p.Asp166Gly) can act as dominant-negative by forming inactive heterodimers with wild-type caspase 3.

Gene Ontology (GO)

• cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153) • execution phase of apoptosis (GO:0097194)
• proteolysis (GO:0006508) • apoptotic process (GO:0006915)
• cysteine-type peptidase activity (GO:0008234)

Pathways

Apoptosis (KEGG hsa04210)
Intrinsic Pathway for Apoptosis (Reactome R-HSA-109606)
Extrinsic Pathway for Apoptosis (Reactome R-HSA-5357801)
p53-Dependent G1 DNA Damage Response (Reactome R-HSA-69580)

Protein Summary

Caspase 3 is a 277-amino acid cysteine protease (32 kDa) synthesized as an inactive zymogen (procaspase 3). Proteolytic cleavage at Asp175/Ser176 generates the active heterodimer composed of a 17 kDa (p17) and a 12 kDa (p12) subunit. The active site contains a catalytic dyad (Cys163, His121) that cleaves substrates after Asp-Glu-Val-Asp (DEVD) motifs. Caspase 3 is the primary executioner caspase, responsible for chromatin condensation, DNA fragmentation, and cell disassembly during apoptosis.

Related Products

Product name Cat.No. Species Gene ID
CASP3 Knockout HEK293 Cell Line EDJ-KQ632 Human 836 Details Get a Quote
CASP3 Knockout HCT 116 Cell Line EDJ-KQ18053 Human 836 Details Get a Quote
CASP3 Knockout A-549 Cell Line EDC07646 Human 836 Details Get a Quote
CASP3 Knockout HeLa Cell Line EDJ-KQ19099 Human 836 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: